Companies
Add Entity
snc-logo

Startup Nation Finder

Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
My Saved Searches
Following
Inbox
My Watchlists
About Us
Glossary

Your CSV is on the way

We’ve sent your CSV file to
send file

Provide your business email

To complete this action, please provide your Business email.

Verify your business email

You only need to verify it once.
We’ve sent a verification link to

Create Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
0/300
Notifications Off
Public content (accessible by all Finder users)

Add to List

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Create Free Account
    Lock Icon
    Lock Icon
    8 Characters, Uppercase letter (A-Z),
    Lowercase letter (a-z), Digit (0-9)
    Lock Icon
    Passwords do not match
    Already have an account? Sign In
    Or continue with

    Verify your email

    We’ve sent a verification link to [email protected]
    Sign in
    Lock Icon
    Lock Icon
    Reset password
    Don't have an account? Create Account
    Or continue with

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    disclaimer-icon
    Summary generated by AI
    Read article
    snackbar-icon
    title
    message
    Search Startups

    Tagged as ('immunotherapy') Startups

    Filters
    Clear

    Search by tag (1)

    All of
    Any of
    None of

    Sector 

    Primary Sector 

    Target Customer 

    Core Technology 

    Funding Stage 

    Founded 

    From
    To

    Total Raised 

    Min
    Max

    Market Cap 

    Min
    Max

    Business Models 

    Product Stage 

    Employees 

    Location 

    Status 
    47 Startups 7 In the News 8 Recently Updated
    • Total Funding
      $1.24B
      Raised
      88
      Events
    • Private Funding
      $755.6M
      Raised
      48
      Rounds
    • Public Offerings
      $481.5M
      Raised
      40
      Offerings
    • M&A
      $0
      Raised
      0
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags

    There aren’t any companies that match your search
    you can try looking for something else.

    BiolineRx logo

    BiolineRx

    Public
    Oncology Therapeutic Pharmaceutical Candidates
    2003 B2B 51-200 Public $222.74M
    viral-diseases
    cancer
    inflammatory-diseases
    pharma-companies
    drug-discovery
    pharmaceuticals
    cancer-therapy
    immunotherapy
    oncology
    Canopy Immuno-Therapeutics logo

    Canopy Immuno-Therapeutics

    Immunotherapeutic Approach for Autoimmunity and Life-threatening Allergies
    2020 B2B 1-10 Seed Undisclosed
    biotechnology
    inflammatory-diseases
    allergy
    treatments
    artificial-intelligence
    software-platform
    life-sciences
    immunology
    immuno-theraphy
    drug-development
    immunotherapy
    Compugen logo

    Compugen

    Public
    Drug Discovery Using Computational Modeling
    1993 B2B 51-200 Public $141.92M
    immunology
    oncology
    biotechnology
    bioinformatics
    antibodies
    drug-discovery
    proteins
    pharmaceuticals
    immunotherapy
    cancer-therapy
    autoimmune-diseases
    patients
    pharma-companies
    cancer
    Enlivex Therapeutics logo

    Enlivex Therapeutics

    Public
    Macrophage Reprogramming Cell Therapies for Life-threatening Diseases
    2005 B2B 11-50 Public $74.9M
    cell-therapy
    inflammatory-diseases
    crohn's-disease
    pharmaceuticals
    cancer
    immunology
    immunotherapy
    pharma-companies
    chronic-patients
    patients
    autoimmune-diseases
    OncoHost logo

    OncoHost

    Precision Diagnostics and Predictive Biomarker Development
    2017 B2B, B2B2C, B2C 51-200 C $50.6M
    pharmaceuticals
    oncology
    cancer
    personalized-medicine
    diagnostics
    data-analytics
    artificial-intelligence
    blood-test
    machine-learning
    cancer-therapy
    bioinformatics
    treatments
    decision-support
    digital-healthcare
    bioconvergence
    immunotherapy
    Purple Biotech logo

    Purple Biotech

    Public
    Tumor-immune Evasion and Drug Resistance Therapies
    1968 B2B 11-50 Public $87.5M
    immunotherapy
    antibodies
    pharmaceuticals
    oncology
    cancer
    cancer-therapy
    drug-development
    Scinai Immunotherapeutics logo

    Scinai Immunotherapeutics

    Public
    Innovative Immunotherapeutic Treatments
    2003 B2B, B2B2C 11-50 Public $63.69M
    immunotherapy
    autoimmune-diseases
    pharmaceuticals
    viral-diseases
    biotechnology
    therapeutics
    infectious-disease
    drug-discovery
    treatments
    drug-delivery
    biopharmaceutical
    vaccines
    patients
    nanotechnology

    Notifications settings

    Off
    Frequency:
    Select all

    Search Startups

    47 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $1.24B
      Raised
      88
      Events
    • Private Funding
      $755.6M
      Raised
      48
      Rounds
    • Public Offerings
      $481.5M
      Raised
      40
      Offerings
    • M&A
      $0
      Raised
      0
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    There aren’t any companies that match your search
    you can try looking for something else.

    BiolineRx logo
    Raised
    $222.74M
    BiolineRx
    Public
    Oncology Therapeutic Pharmaceutical Candidates
    Founded:2003
    Business Model:B2B
    Employees:51-200
    Funding Stage:Public
    Canopy Immuno-Therapeutics logo
    Raised
    Undisclosed
    Canopy Immuno-Therapeutics
    Immunotherapeutic Approach for Autoimmunity and Life-threatening Allergies
    Founded:2020
    Business Model:B2B
    Employees:1-10
    Funding Stage:Seed
    Compugen logo
    Raised
    $141.92M
    Compugen
    Public
    Drug Discovery Using Computational Modeling
    Founded:1993
    Business Model:B2B
    Employees:51-200
    Funding Stage:Public
    Enlivex Therapeutics logo
    Raised
    $74.9M
    Enlivex Therapeutics
    Public
    Macrophage Reprogramming Cell Therapies for Life-threatening Diseases
    Founded:2005
    Business Model:B2B
    Employees:11-50
    Funding Stage:Public
    OncoHost logo
    Raised
    $50.6M
    OncoHost
    Precision Diagnostics and Predictive Biomarker Development
    Founded:2017
    Business Model:B2B, B2B2C, B2C
    Employees:51-200
    Funding Stage:C
    Purple Biotech logo
    Raised
    $87.5M
    Purple Biotech
    Public
    Tumor-immune Evasion and Drug Resistance Therapies
    Founded:1968
    Business Model:B2B
    Employees:11-50
    Funding Stage:Public
    Scinai Immunotherapeutics logo
    Raised
    $63.69M
    Scinai Immunotherapeutics
    Public
    Innovative Immunotherapeutic Treatments
    Founded:2003
    Business Model:B2B, B2B2C
    Employees:11-50
    Funding Stage:Public
    Access Comprehensive Financial Analytics
    Create a free account to:
    • Explore detailed financial analytics.
    • Track company growth and size.
    • Connect with company team members.
    I already have access,
    I already have access,